A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2017

Conditions

Recreational Drug UsePrescription Drug Abuse (Not Dependent)

Interventions

DRUG

Lasmiditan

Administered orally

DRUG

Alprazolam

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

Vince & Associates Clinical Research, Inc., Overland Park

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03286218 - A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users | Biotech Hunter | Biotech Hunter